Pancreatic Cancer Research

ResearcherPeking University Third HospitalActive in the last 2 years

Dianrong Xiu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9109-3868; OpenAlex author ID A5044329598. Sources: OpenAlex.

Their work

Papers
22 (first author 0, last author 14)
Trials
0
Grants
0
Labs led
1
Collaborators
46
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 4 papers · 2017: 2 papers · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: 4 papers · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 22

  1. Multiparametric quantitative diffusion weighted magnetic resonance imaging can effectively predict the response to neoadjuvant therapy in borderline resectable… Last author DOI 10.1016/j.ejrad.2024.111893↗
  2. Robotic versus laparoscopic distal pancreatectomy for pancreatic adenocarcinoma in obese patients. Co-author DOI 10.1002/rcs.2596↗
  3. Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/02841851221142552↗
  4. Application of Magnetic Resonance Imaging in Neoadjuvant Treatment of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1002/jmri.28096↗
  5. Should Positive Cytology Revealed by Intraoperative Lavage Preclude Radical Resection in Resectable Pancreatic Cancer?: A Systemic Review and Meta-analysis. Last author DOI 10.1097/mpa.0000000000002163↗
  6. The effect of minimally invasive or open radical antegrade modular pancreatosplenectomy on pancreatic cancer: A multicenter randomized clinical trial protocol. Co-author DOI 10.3389/fonc.2022.965508↗
  7. Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers14174243↗
  8. Nomogram and competing risk model to predict recurrence after curative surgical resection of PDAC. Last author DOI 10.1016/j.pan.2021.04.010↗
  9. Integrated proteomics and phosphoproteomics reveal perturbed regulative pathways in pancreatic ductal adenocarcinoma. Co-author DOI 10.1039/d0mo00125b↗
  10. A nomogram of preoperative predictors for occult metastasis in patients with PDAC during laparoscopic exploration. Last author DOI 10.21037/gs-20-605↗
  11. Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer. Last author DOI 10.3389/fonc.2021.619517↗
  12. The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis. Last author DOI 10.1007/s00280-020-04165-2↗
  13. Postoperative metastasis prediction based on portal vein circulating tumor cells detected by flow cytometry in periampullary or pancreatic cancer. Last author DOI 10.2147/cmar.s210332↗
  14. The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis. Last author DOI 10.1097/md.0000000000010088↗
  15. G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma. Last author DOI 10.2147/cmar.s165226↗
  16. Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study. Last author DOI 10.2147/cmar.s145722↗
  17. Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis. Last author DOI 10.2147/ott.s142022↗
  18. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis. Co-author DOI 10.1097/md.0000000000004932↗
  19. Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis. Co-author DOI 10.1186/s12957-016-0888-3↗
  20. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.18632/oncotarget.11031↗
  21. Parasympathetic neurogenesis is strongly associated with tumor budding and correlates with an adverse prognosis in pancreatic ductal adenocarcinoma. Last author DOI 10.21147/j.issn.1000-9604.2016.02.05↗
  22. Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway. Co-author DOI 10.1111/dom.12291↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunhui Yuan · 9 shared papers, 2016–2022 · strength 0.97
  2. Lianyuan Tao · 9 shared papers, 2016–2021 · strength 0.84
  3. Piaoe Zeng · 4 shared papers, 2022–2025 · strength 0.82
  4. Chao Qu · 4 shared papers, 2022–2025 · strength 0.82
  5. Bin Jiang · 8 shared papers, 2016–2021 · strength 0.78
  6. Lingfu Zhang · 8 shared papers, 2016–2022 · strength 0.71
  7. Chunhui Yuan · 5 shared papers, 2017–2022 · strength 0.67
  8. Lei Li · 3 shared papers, 2021–2022 · strength 0.45
  9. Huishu Yuan · 2 shared papers, 2022–2025 · strength 0.43
  10. Jiachen Ge · 2 shared papers, 2021 · strength 0.27
  11. Jingyu Cao · 1 shared paper, 2025 · strength 0.27
  12. Huishu Yuan · 1 shared paper, 2023 · strength 0.20
  13. Bingqi Li · 1 shared paper, 2022 · strength 0.17
  14. Lijun Zhong · 1 shared paper, 2021 · strength 0.16
  15. Juntuo Zhou · 1 shared paper, 2021 · strength 0.16
  16. Muxing Li · 1 shared paper, 2021 · strength 0.14
  17. Li Zhang · 1 shared paper, 2021 · strength 0.14
  18. Laleh Golkar Melstrom · 1 shared paper, 2023 · strength 0.13
  19. Fabio Ausania · 1 shared paper, 2023 · strength 0.13
  20. Steven Alan White · 1 shared paper, 2023 · strength 0.13
  21. Riccardo Memeo · 1 shared paper, 2023 · strength 0.13
  22. John B. Martinie · 1 shared paper, 2023 · strength 0.13
  23. Yuman Fong · 1 shared paper, 2023 · strength 0.13
  24. Carolina González Abós · 1 shared paper, 2023 · strength 0.13
  25. Gregorio Di Franco · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.